Found: 20
Select item for more details and to access through your institution.
Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal cancer—Results of the prospective multicenter PERMAD trial.
- Published in:
- PLoS ONE, 2024, v. 19, n. 6, p. 1, doi. 10.1371/journal.pone.0304324
- By:
- Publication type:
- Article
Adjuvant Treatment with S-1 in Patients after R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction: A Multicenter Phase I/II Feasibility Study (GMBH-STO-0114).
- Published in:
- Oncology Research & Treatment, 2024, v. 47, n. 6, p. 251, doi. 10.1159/000538143
- By:
- Publication type:
- Article
Applicability of the CT Radiomics of Skeletal Muscle and Machine Learning for the Detection of Sarcopenia and Prognostic Assessment of Disease Progression in Patients with Gastric and Esophageal Tumors.
- Published in:
- Diagnostics (2075-4418), 2024, v. 14, n. 2, p. 198, doi. 10.3390/diagnostics14020198
- By:
- Publication type:
- Article
Gastroenteropancreatic Neuroendocrine Tumors—Current Status and Advances in Diagnostic Imaging.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 17, p. 2741, doi. 10.3390/diagnostics13172741
- By:
- Publication type:
- Article
Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh ®TM) Methodology—A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer.
- Published in:
- Current Oncology, 2023, v. 30, n. 6, p. 5828, doi. 10.3390/curroncol30060436
- By:
- Publication type:
- Article
Comparative Panel Sequencing of DNA Variants in cf-, ev- and tumorDNA for Pancreatic Ductal Adenocarcinoma Patients.
- Published in:
- Cancers, 2022, v. 14, n. 4, p. 1074, doi. 10.3390/cancers14041074
- By:
- Publication type:
- Article
Pancreatic Cancer: Current Multimodality Treatment Options and the Future Impact of Molecular Biological Profiling.
- Published in:
- Visceral Medicine, 2022, v. 38, n. 1, p. 20, doi. 10.1159/000521631
- By:
- Publication type:
- Article
The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and Therapy.
- Published in:
- Cancers, 2022, v. 14, n. 1, p. 217, doi. 10.3390/cancers14010217
- By:
- Publication type:
- Article
Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Systemic Therapy for Metastatic Pancreatic Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 4, p. 360, doi. 10.1159/000515490
- By:
- Publication type:
- Article
A Prospective Feasibility Trial to Challenge Patient–Derived Pancreatic Cancer Organoids in Predicting Treatment Response.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2539, doi. 10.3390/cancers13112539
- By:
- Publication type:
- Article
Nintedanib plus mFOLFOX6 as second‐line treatment of metastatic, chemorefractory colorectal cancer: The randomised, placebo‐controlled, phase II TRICC‐C study (AIO‐KRK‐0111).
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 6, p. 1428, doi. 10.1002/ijc.33296
- By:
- Publication type:
- Article
Evaluation of EGFR inhibitor‐mediated acneiform skin toxicity within the double‐blind randomized EVITA trial: A thorough gender‐specific analysis using the WoMo score.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 9, p. 4169, doi. 10.1002/cam4.2132
- By:
- Publication type:
- Article
Molecular Approaches to Metastatic Colorectal Cancer: Better Diagnosis – Better Treatment?
- Published in:
- Visceral Medicine, 2019, v. 35, n. 4, p. 259, doi. 10.1159/000500617
- By:
- Publication type:
- Article
Immunotherapy: Pancreatic Cancer and Extrahepatic Biliary Tract Cancer.
- Published in:
- Visceral Medicine, 2019, v. 35, n. 1, p. 28, doi. 10.1159/000497291
- By:
- Publication type:
- Article
Feasibility and safety of nivolumab in advanced hepatocellular carcinoma: real-life experience from three German centers.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 1, p. 253, doi. 10.1007/s00432-018-2780-8
- By:
- Publication type:
- Article
Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Treatment monitoring in metastatic colorectal cancer patients by quantification and KRAS genotyping of circulating cell-free DNA.
- Published in:
- PLoS ONE, 2017, v. 12, n. 3, p. 1, doi. 10.1371/journal.pone.0174308
- By:
- Publication type:
- Article
DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article